Clinical Trials Directory

Trials / Completed

CompletedNCT00583609

A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Braintree Laboratories · Industry
Sex
All
Age
4 Years – 16 Years
Healthy volunteers
Not accepted

Summary

To evaluate the patient acceptance of a new PEG3350 dose formulation in children currently treated with PEG3350 powder for treatment of constipation.

Conditions

Interventions

TypeNameDescription
DRUGPEG3350PEG3350

Timeline

Start date
2007-09-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2007-12-31
Last updated
2009-09-28

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00583609. Inclusion in this directory is not an endorsement.

A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children (NCT00583609) · Clinical Trials Directory